Archives Of Family Medicine – November 1992

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

Objawy ADHD Wystepuja
Occurring ADHD symptoms

Generic name/category: Disease awareness
Company: Lilly
Country/Market: Poland, Europe
Indication(s)/use: Attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: Answers that matter.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczn – June 2009

For patients with life-threatening fungal infections
There's no time for a second chance

Voriconazole (VFEND, Pfizer) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.

More on Wikipedia

Brand name: Vfend
Generic name/category: Voriconazole, Antifungals, Triazoles
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: invasive fungal infections, candidiasis, aspergillosis, and certain emerging fungal infections.
Target: Healthcare Professionals (HCP)
Tagline: When it matters most
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – August 20, 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads

The time is right for innovative research in osteoporosis

Research pinpoints Rank ligand as a key player in bone loss.

RANKL (Receptor Activator for Nuclear Factor ?? B Ligand), also known as TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and ODF (osteoclast differentiation factor), is a molecule important in bone metabolism. This natural and necessary surface-bound molecule activates osteoclasts, cells involved in bone resorption. Overproduction of RANKL is implicated in a variety of degenerative bone diseases, such as rheumatoid arthritis and psoriatic arthritis.

More on Wikipedia

Generic name/category: Rank ligand, TNF-related
Company: Amgen
Country/Market: Canada, North America
Indication(s)/use: osteoporosis
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: CMAJ – September 1, 2009

To see all of this brand's ads on AdPharm, click here
0 views
Sep 09, 2009

Visit AdPharm.net for more pharmaceutical ads

Now approved for acquired hemophilia
With a life-threatening acquired hemophilia bleed, every minute counts.
Stop it with NovoSeven

For options on how to access NovoSeven, go to accessnovoseven.com or call 1-877-NOVO-777

Recombinant human factor VIIa (NovoSeven, eptacog alfa [activated], ATC code B02BD08) has been introduced for use in uncontrollable bleeding in hemophilia patients (with Factor VIII or IX deficiency) who have developed inhibitors against replacement coagulation factor.

It is being increasingly used in uncontrollable hemorrhage. The first report of its use was in an Israeli soldier with uncontrollable bleeding in 1999. The rationale for its use in hemorrhage is, that it will only induce coagulation in those sites where tissue factor (TF) is also present. Still, O'Connell et al. report an increased risk of deep vein thrombosis, pulmonary embolism and myocardial infarction in association with the use of rhFVIIa.

According to a 2005 study, recombinant human factor VII improves outcomes in acute intracerebral hemorrhage.

More on Wikipedia

From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)

Brand name: NovoSeven
Generic name/category: Eptacog alfa (activated)
Company: Novo Nordisk
Country/Market: USA, North America
Indication(s)/use: uncontrollable hemorrhage, acquired haemophilia
Target: Healthcare Professionals (HCP)
Tagline: Let nothing inhibit their passion
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007

To see all of this brand's ads on AdPharm, click here
0 views
Aug 23, 2009

Visit AdPharm.net for more pharmaceutical ads

Now approved for acquired hemophilia
With a life-threatening acquired hemophilia bleed, every minute counts.
Stop it with NovoSeven

For options on how to access NovoSeven, go to accessnovoseven.com or call 1-877-NOVO-777

Brand name: NovoSeven
Generic name/category: Eptacog alfa (activated)
Company: Novo Nordisk
Country/Market: USA, North America
Indication(s)/use: uncontrollable hemorrhage, acquired haemophilia
Target: Healthcare Professionals (HCP)
Tagline: Let nothing inhibit their passion
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007

To see all of this brand’s ads on AdPharm, click here